Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 6
1953 1
1956 2
1957 1
1958 2
1959 1
1960 2
1961 5
1962 5
1963 12
1964 5
1965 13
1966 3
1967 11
1968 18
1969 12
1970 10
1971 11
1972 9
1973 8
1974 16
1975 27
1976 26
1977 30
1978 32
1979 21
1980 35
1981 38
1982 48
1983 42
1984 35
1985 45
1986 42
1987 53
1988 57
1989 67
1990 63
1991 58
1992 56
1993 55
1994 66
1995 86
1996 100
1997 98
1998 128
1999 126
2000 123
2001 165
2002 148
2003 120
2004 128
2005 142
2006 131
2007 161
2008 159
2009 140
2010 157
2011 164
2012 179
2013 199
2014 218
2015 275
2016 294
2017 301
2018 255
2019 270
2020 350
2021 333
2022 358
2023 313
2024 222
2025 2

Text availability

Article attribute

Article type

Publication date

Search Results

6,240 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.
Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M, Maruhashi T, Tanaka A, Morikawa N, Nishimiya K, Akashi N, Tanaka Y, Otani N, Morita M, Miyata H, Takada T, Tsutani H, Ogino K, Ichida K, Hisatome I, Abe K. Kuwabara M, et al. Among authors: tanaka a. Biomolecules. 2023 Oct 13;13(10):1519. doi: 10.3390/biom13101519. Biomolecules. 2023. PMID: 37892201 Free PMC article. Review.
Author's reply.
Iwama M, Noda T, Takagi K, Tanaka A, Murohara T. Iwama M, et al. Among authors: tanaka a. J Cardiol. 2023 Nov;82(5):429-430. doi: 10.1016/j.jjcc.2023.08.015. Epub 2023 Sep 4. J Cardiol. 2023. PMID: 37666322 No abstract available.
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus.
Levy C, Kendrick S, Bowlus CL, Tanaka A, Jones D, Kremer AE, Mayo MJ, Haque N, von Maltzahn R, Allinder M, Swift B, McLaughlin MM, Hirschfield GM; GLIMMER Study Group. Levy C, et al. Among authors: tanaka a. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1902-1912.e13. doi: 10.1016/j.cgh.2022.10.032. Epub 2022 Nov 4. Clin Gastroenterol Hepatol. 2023. PMID: 36343847 Free article. Clinical Trial.
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA).
Tanaka A, Taguchi I, Hisauchi I, Yoshida H, Shimabukuro M, Hongo H, Ishikawa T, Kadokami T, Yagi S, Sata M, Node K; DIANA study investigators. Tanaka A, et al. Eur J Med Res. 2023 Jul 17;28(1):238. doi: 10.1186/s40001-023-01208-1. Eur J Med Res. 2023. PMID: 37461063 Free PMC article.
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.
Xiao M, Kondo S, Nomura M, Kato S, Nishimura K, Zang W, Zhang Y, Akashi T, Viny A, Shigehiro T, Ikawa T, Yamazaki H, Fukumoto M, Tanaka A, Hayashi Y, Koike Y, Aoyama Y, Ito H, Nishikawa H, Kitamura T, Kanai A, Yokoyama A, Fujiwara T, Goyama S, Noguchi H, Lee SC, Toyoda A, Hinohara K, Abdel-Wahab O, Inoue D. Xiao M, et al. Among authors: tanaka a. Nat Commun. 2023 Dec 15;14(1):8372. doi: 10.1038/s41467-023-44081-6. Nat Commun. 2023. PMID: 38102116 Free PMC article.
2023 update and perspectives.
Mogi M, Tanaka A, Node K, Tomitani N, Hoshide S, Narita K, Nozato Y, Katsurada K, Maruhashi T, Higashi Y, Matsumoto C, Bokuda K, Yoshida Y, Shibata H, Toba A, Masuda T, Nagata D, Nagai M, Shinohara K, Kitada K, Kuwabara M, Kodama T, Kario K. Mogi M, et al. Among authors: tanaka a. Hypertens Res. 2024 Jan;47(1):6-32. doi: 10.1038/s41440-023-01398-5. Epub 2023 Sep 15. Hypertens Res. 2024. PMID: 37710033 Review.
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR).
Tanaka A, Shibata H, Imai T, Yoshida H, Miyazono M, Takahashi N, Fukuda D, Okada Y, Teragawa H, Suwa S, Kida K, Moroi M, Taguchi I, Toyoda S, Shimabukuro M, Tanabe K, Tanaka K, Nangaku M, Node K; FIVE-STAR trial investigators. Tanaka A, et al. Cardiovasc Diabetol. 2023 Jul 31;22(1):194. doi: 10.1186/s12933-023-01928-y. Cardiovasc Diabetol. 2023. PMID: 37525257 Free PMC article. Clinical Trial.
6,240 results